sequencing-based clinical microbiome test

See the following -

Are We Ready for Consumer Microbiome Testing?

Juliet Preston | MedCity News | November 9, 2016

Some people collect stamps. uBiome has a different area of interest. Since 2012, the San Francisco, California, startup has received and analyzed nearly 100,000 stool samples from customers trying to understand the unique population of microorganisms that call their body ‘home.’ It’s now preparing to scale-up and diversify its testing options, with the help a $15.5 million Series B funding round that was announced in early November. An alum of the Y Combinator, uBiome has grand plans. But is the microbiome science really there?...

Read More »

uBiome Reveals Details of Clinical Screening Test for Gut Health

Press Release | uBiome | November 3, 2016

Leading microbial genomics company uBiome has released a preprint of a publication submitted for peer review, entitled “16S rRNA Gene Sequencing as a Clinical Diagnostic Aid for Gastrointestinal-related Condition.” Details are available to the public in a preprint on the online archive BioRxiv. The pre-print comes alongside the announcement of the world’s first sequencing-based clinical microbiome test, SmartGut™. SmartGut™ enables physicians and patients to access a comprehensive microbiome screening test with a simple, at-home sample collection, to identify important commensal and pathogenic microorganisms...

Read More »